| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |